Skip to main content
NCBI home page
Canadian Family Physician logoLink to Canadian Family Physician
. 1983 Nov;29:2121–2124.

A Review of Non-Steroidal Anti-Inflammatory Drugs

David Rosenbloom, Marilyn A Craven
PMCID: PMC2154295  PMID: 21283472

Abstract

An increasing number of non-steroidal anti-inflammatory drugs (NSAIDs) is available for clinical use each year. This article reviews significant differences between NSAIDs currently available in Canada, and helps the clinician to evaluate new NSAIDs. While their mechanism of action and efficacy are similar, side effects and cost vary considerably from one agent to another. Because all NSAIDs can produce adverse effects, patients, especially if they are elderly, should be selected carefully for treatment with a particular agent.

Full text

PDF
2121

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aarons L., Grennan D. M., Rajapakse C., Brinkley J., Siddiqui M., Taylor L., Higham C. Anti-inflammatory (ibuprofen) drug therapy in rheumatoid arthritis--rate of response and lack of time dependency of plasma pharmacokinetics. Br J Clin Pharmacol. 1983 Mar;15(3):387–388. doi: 10.1111/j.1365-2125.1983.tb01517.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ashraf M., Pearson R. M., Winfield D. A. Aplastic anaemia associated with fenoprofen. Br Med J (Clin Res Ed) 1982 May 1;284(6325):1301–1302. doi: 10.1136/bmj.284.6325.1301-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bach G. L. Comparative clinical trials with diclofenac sodium (Voltarol) and naproxen in rheumatic conditions: investigation of possible changes in diclofenac dose and dose interval. Rheumatol Rehabil. 1979;Suppl 2:69–74. [PubMed] [Google Scholar]
  4. Brand F. N., Smith R. T., Brand P. A. Effect of economic barriers to medical care on patients' noncompliance. Public Health Rep. 1977 Jan-Feb;92(1):72–78. [PMC free article] [PubMed] [Google Scholar]
  5. Capell H. A., Rennie J. A., Rooney P. J., Murdoch R. M., Hole D. J., Dick W. C., Buchanan W. W. Patient compliance: a novel method of testing non-steroidal antiinflammatory analgesics in rheumatoid arthritis. J Rheumatol. 1979 Sep-Oct;6(5):584–593. [PubMed] [Google Scholar]
  6. Deyo R. A., Inui T. S., Sullivan B. Noncompliance with arthritis drugs: magnitude, correlates, and clinical implications. J Rheumatol. 1981 Nov-Dec;8(6):931–936. [PubMed] [Google Scholar]
  7. Emery P., Grahame R. Gastrointestinal blood loss and piroxicam. Lancet. 1982 Jun 5;1(8284):1302–1303. doi: 10.1016/s0140-6736(82)92864-1. [DOI] [PubMed] [Google Scholar]
  8. Favre L., Glasson P., Vallotton M. B. Reversible acute renal failure from combined triamterene and indomethacin: a study in healthy subjects. Ann Intern Med. 1982 Mar;96(3):317–320. doi: 10.7326/0003-4819-96-3-317. [DOI] [PubMed] [Google Scholar]
  9. Galler M., Folkert V. W., Schlondorff D. Reversible acute renal insufficiency and hyperkalemia following indomethacin therapy. JAMA. 1981 Jul 10;246(2):154–155. [PubMed] [Google Scholar]
  10. Gerber L. H., Rooney P. J., McCarthy D. M. Healing of peptic ulcers during continuing anti-inflammatory drug therapy in rheumatoid arthritis. J Clin Gastroenterol. 1981 Mar;3(1):7–11. doi: 10.1097/00004836-198103000-00002. [DOI] [PubMed] [Google Scholar]
  11. Goldstein J., Laskin D. A., Ginsberg G. H. Sulindac associated with pancreatitis. Ann Intern Med. 1980 Jul;93(1):151–151. doi: 10.7326/0003-4819-93-1-151_1. [DOI] [PubMed] [Google Scholar]
  12. Grennan D. M., Ferry D. G., Ashworth M. E., Kenny R. E., Mackinnon M. The aspirin-ibuprofen interaction in rheumatoid arthritis. Br J Clin Pharmacol. 1979 Nov;8(5):497–503. doi: 10.1111/j.1365-2125.1979.tb01033.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hasiba U., Scranton P. E., Lewis J. H., Spero J. A. Efficacy and safety of ibuprofen for hemophilic arthropathy. Arch Intern Med. 1980 Dec;140(12):1583–1585. [PubMed] [Google Scholar]
  14. Hoftiezer J. W., Silvoso G. R., Burks M., Ivey K. J. Comparison of the effects of regular and enteric-coated aspirin on gastroduodenal mucosa of man. Lancet. 1980 Sep 20;2(8195 Pt 1):609–612. doi: 10.1016/s0140-6736(80)90282-2. [DOI] [PubMed] [Google Scholar]
  15. Inman W. H. Study of fatal bone marrow depression with special reference to phenylbutazone and oxyphenbutazone. Br Med J. 1977 Jun 11;1(6075):1500–1505. doi: 10.1136/bmj.1.6075.1500. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Katz S. M., Capaldo R., Everts E. A., DiGregorio J. G. Tolmetin. Association with reversible renal failure and acute interstitial nephritis. JAMA. 1981 Jul 17;246(3):243–245. doi: 10.1001/jama.246.3.243. [DOI] [PubMed] [Google Scholar]
  17. Kimberly R. P., Bowden R. E., Keiser H. R., Plotz P. H. Reduction of renal function by newer nonsteroidal anti-inflammatory drugs. Am J Med. 1978 May;64(5):804–807. doi: 10.1016/0002-9343(78)90520-x. [DOI] [PubMed] [Google Scholar]
  18. Lanza F. L., Royer G. L., Jr, Nelson R. S. Endoscopic evaluation of the effects of aspirin, buffered aspirin, and enteric-coated aspirin on gastric and duodenal mucosa. N Engl J Med. 1980 Jul 17;303(3):136–138. doi: 10.1056/NEJM198007173030305. [DOI] [PubMed] [Google Scholar]
  19. Lee P., Tan L. J. Drug compliance in outpatients with rheumatoid arthritis. Aust N Z J Med. 1979 Jun;9(3):274–277. doi: 10.1111/j.1445-5994.1979.tb04138.x. [DOI] [PubMed] [Google Scholar]
  20. Levy M. Aspirin use in patients with major upper gastrointestinal bleeding and peptic-ulcer disease. A report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center. N Engl J Med. 1974 May 23;290(21):1158–1162. doi: 10.1056/NEJM197405232902102. [DOI] [PubMed] [Google Scholar]
  21. Lomvardias S., Pinn V. W., Wadhwa M. L., Koshy K. M., Heller M. Nephrotic syndrome associated with sulindac. N Engl J Med. 1981 Feb 12;304(7):424–424. doi: 10.1056/NEJM198102123040715. [DOI] [PubMed] [Google Scholar]
  22. Mongan E., Kelly P., Nies K., Porter W. W., Paulus H. E. Tinnitus as an indication of therapeutic serum salicylate levels. JAMA. 1973 Oct 8;226(2):142–145. [PubMed] [Google Scholar]
  23. Nadell J., Bruno J., Varady J., Segre E. J. Effect of naproxen and of aspirin on bleeding time and platelet aggregation. J Clin Pharmacol. 1974 Apr;14(4):176–182. doi: 10.1002/j.1552-4604.1974.tb01395.x. [DOI] [PubMed] [Google Scholar]
  24. Park G. D., Spector R., Headstream T., Goldberg M. Serious adverse reactions associated with sulindac. Arch Intern Med. 1982 Jul;142(7):1292–1294. [PubMed] [Google Scholar]
  25. Renal effects of fenoprofen. Ann Intern Med. 1980 Sep;93(3):508–509. doi: 10.7326/0003-4819-93-3-508. [DOI] [PubMed] [Google Scholar]
  26. Robertson C. E., Ford M. J., Van Someren V., Dlugolecka M., Prescott L. F. Mefenamic acid nephropathy. Lancet. 1980 Aug 2;2(8188):232–233. doi: 10.1016/s0140-6736(80)90122-1. [DOI] [PubMed] [Google Scholar]
  27. Rossi A. C., Knapp D. E. Tolmetin-induced anaphylactoid reactions. N Engl J Med. 1982 Aug 19;307(8):499–500. doi: 10.1056/NEJM198208193070815. [DOI] [PubMed] [Google Scholar]
  28. Szczeklik A., Gryglewski R. J. Asthma and anti-inflammatory drugs. Mechanisms and clinical patterns. Drugs. 1983 Jun;25(6):533–543. doi: 10.2165/00003495-198325060-00001. [DOI] [PubMed] [Google Scholar]
  29. Taggart A. J., Johnston G. D., McDevitt D. G. Does the frequency of daily dosage influence compliance with digoxin therapy? Br J Clin Pharmacol. 1981 Jan;11(1):31–34. doi: 10.1111/j.1365-2125.1981.tb01098.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Willkens R. F., Segre E. J. Combination therapy with naproxen and aspirin in rheumatoid arthritis. Arthritis Rheum. 1976 Jul-Aug;19(4):677–682. doi: 10.1002/1529-0131(197607/08)19:4<677::aid-art1780190404>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  31. Wright V., Amos R. Do drugs change the course of rheumatoid arthritis? Br Med J. 1980 Apr 5;280(6219):964–966. doi: 10.1136/bmj.280.6219.964-a. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Canadian Family Physician are provided here courtesy of College of Family Physicians of Canada

RESOURCES